Results 151 to 160 of about 3,195 (172)

High-throughput screening of monoclonal antibodies against carbapenemases using a multiplex protein microarray platform. [PDF]

open access: yesFront Microbiol
Braun SD   +8 more
europepmc   +1 more source

First report of Escherichia coli co-producing NDM-1 and OXA-232

Diagnostic Microbiology and Infectious Disease, 2016
Recently Gram-negative bacteria co-producing multiple carbapenemases have emerged in different parts of the world. We report the first isolation of an Escherichia coli strain co-producing the carbapenemases NDM-1 and OXA-232.
Jiabin Huang   +2 more
exaly   +3 more sources

First report of OXA-232-producing Klebsiella pneumoniae strains in Tunisia

Diagnostic Microbiology and Infectious Disease, 2017
Eleven carbapenem-resistant Klebsiella pneumoniae isolates were recovered from the military hospital of Tunis, Tunisia. Three of these isolates carried the carbapenemase blaOXA-232 gene recently identified in France. These isolates were clonally related and co-expressed the extended-spectrum ß-lactamase, CTX-M-15. This work identified the occurrence of
Rémy A Bonnin, Thierry Naas
exaly   +3 more sources

Emergence and nosocomial spread of carbapenem-resistant OXA-232-producing Klebsiella pneumoniae in Brunei Darussalam

open access: yesJournal of Global Antimicrobial Resistance, 2017
Carbapenem-resistant Enterobacteriaceae (CRE) are identified as a major global health concern. The success of CRE is facilitated by the emergence, acquisition and spread of successful clones carrying plasmid-encoded resistance genes. In this study, an outbreak of carbapenem-resistant Klebsiella pneumoniae (CRKP) infections in patients hospitalised in ...
D Wdavid W Wareham   +1 more
exaly   +6 more sources

Genetic and biochemical characterisation of OXA-232, a carbapenem-hydrolysing class D β-lactamase from Enterobacteriaceae

International Journal of Antimicrobial Agents, 2013
Three enterobacterial isolates (two Klebsiella pneumoniae and one Escherichia coli) were recovered from three patients transferred from India to France in 2011. All three isolates were resistant or of intermediate susceptibility to all β-lactams and of decreased susceptibility to carbapenems.
Laurent Poirel, Patrice Nordmann
exaly   +6 more sources

Home - About - Disclaimer - Privacy